133 related articles for article (PubMed ID: 18468564)
1. Product-related research: how research can contribute to successful life-cycle management.
Sandner P; Ziegelbauer K
Drug Discov Today; 2008 May; 13(9-10):457-63. PubMed ID: 18468564
[TBL] [Abstract][Full Text] [Related]
2. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
Federsel HJ
Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical research and development.
McKercher PL
Clin Ther; 1992; 14(5):760-4; discussion 759. PubMed ID: 1468093
[TBL] [Abstract][Full Text] [Related]
4. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
5. Clinical research opportunities: what you need to know for your practice.
Glatz NF; Gregory SJ; Law BT; Riner RN
Heart Dis; 2000; 2(4):287-92. PubMed ID: 11728271
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical new product development: the increasing role of in-licensing.
Edwards NV
Anesthesiol Clin; 2008 Dec; 26(4):627-36, v. PubMed ID: 19041620
[TBL] [Abstract][Full Text] [Related]
7. Pharma moves ahead cautiously in China.
Yidong G
Science; 2005 Jul; 309(5735):735. PubMed ID: 16051788
[No Abstract] [Full Text] [Related]
8. Productivity counts--but the definition is key.
Mervis J
Science; 2005 Jul; 309(5735):726. PubMed ID: 16051784
[No Abstract] [Full Text] [Related]
9. [Industry and pharmaceutical research in Italy. How to make up for lost time].
Mortari U
Recenti Prog Med; 2006 Nov; 97(11):634-9. PubMed ID: 17252720
[TBL] [Abstract][Full Text] [Related]
10. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
11. Drug development. A European-inspired renaissance for China's drug industry?
Xin H
Science; 2007 Jul; 317(5837):436-7. PubMed ID: 17656689
[No Abstract] [Full Text] [Related]
12. Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system.
Hughes RO; Walker JK; Cubbage JW; Fobian YM; Rogier DJ; Heasley SE; Blevis-Bal RM; Benson AG; Owen DR; Jacobsen EJ; Freskos JN; Molyneaux JM; Brown DL; Stallings WC; Acker BA; Maddux TM; Tollefson MB; Williams JM; Moon JB; Mischke BV; Rumsey JM; Zheng Y; Macinnes A; Bond BR; Yu Y
Bioorg Med Chem Lett; 2009 Aug; 19(15):4092-6. PubMed ID: 19539468
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical technology management--profitable business avenue.
Puthli SP
Expert Opin Drug Deliv; 2010 Jan; 7(1):1-5. PubMed ID: 20017657
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery and natural products: end of an era or an endless frontier?
Li JW; Vederas JC
Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
[TBL] [Abstract][Full Text] [Related]
15. Advances in knowledge management for pharmaceutical research and development.
Torr-Brown S
Curr Opin Drug Discov Devel; 2005 May; 8(3):316-22. PubMed ID: 15892246
[TBL] [Abstract][Full Text] [Related]
16. Organizing for innovation: towards successful translational research.
West W; Nightingale P
Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
[TBL] [Abstract][Full Text] [Related]
17. A new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic Plan.
Mullins C; Kaplan SA
J Urol; 2009 Mar; 181(3):963-71. PubMed ID: 19150562
[TBL] [Abstract][Full Text] [Related]
18. Conducting pharmaceutical R&D in India - Critical components of entry strategies.
Gulati R
IDrugs; 2008 Nov; 11(11):817-22. PubMed ID: 18988126
[TBL] [Abstract][Full Text] [Related]
19. The year's new drugs & biologics - 2008.
Graul AI; Revel L; Barrionuevo M; Cruces E; Rosa E; Verges C; Lupone B; Diaz N; Castaner R
Drug News Perspect; 2009; 22(1):7-29. PubMed ID: 19209296
[TBL] [Abstract][Full Text] [Related]
20. Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors.
Owen DR; Walker JK; Jon Jacobsen E; Freskos JN; Hughes RO; Brown DL; Bell AS; Brown DG; Phillips C; Mischke BV; Molyneaux JM; Fobian YM; Heasley SE; Moon JB; Stallings WC; Joseph Rogier D; Fox DN; Palmer MJ; Ringer T; Rodriquez-Lens M; Cubbage JW; Blevis-Bal RM; Benson AG; Acker BA; Maddux TM; Tollefson MB; Bond BR; Macinnes A; Yu Y
Bioorg Med Chem Lett; 2009 Aug; 19(15):4088-91. PubMed ID: 19540112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
